WebApr 20, 2024 · A look at Novartis’ share price movement year to date shows that the stock has underperformed the Zacks classified Large Cap Pharma industry. Its shares have declined 0.2%, as against the... WebApr 23, 2024 · Swiss pharma giant Novartis AG NVS is scheduled to report first-quarter 2024 results on Apr 28. The company has a decent track record, beating earnings expectations thrice in the trailing four...
Factors Setting the Tone for Novartis
WebApr 15, 2024 · Novartis (NYSE:NVS – Get Rating) last posted its earnings results on Wednesday, February 1st. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.09. The business had revenue of $12.69 billion for the quarter, compared to analyst estimates of $12.85 billion. WebApr 26, 2024 · During the first quarter, Novartis earned $1.46 a share on $12.53 billion in sales. Earnings just topped expectations by a penny. But sales were below the call from analysts polled by FactSet... circlet of rhaelyx melvor
Novartis Earnings Conference Call Is Coming Up, Here
WebApr 27, 2024 · Novartis reported revenue in the first quarter of $12.4 billion, up 1% year over year on a reported basis but down 2% on a constant-currency basis. This result fell short of the average analyst... WebApr 12, 2024 · Novartis AG has a 1-year low of $74.09 and a 1-year high of $97.00. The company has a current ratio of 1.29, a quick ratio of 1.04 and a debt-to-equity ratio of 0.34. Novartis ( NYSE:NVS - Get Rating) last posted its earnings results on Wednesday, February 1st. The company reported $1.51 earnings per share for the quarter, topping analysts ... WebApr 20, 2024 · Novartis Reports Encouraging Q1 Results. Novartis AG NVS also reported this week. The Swiss pharma giant beat earnings and revenue estimates driven by strong performance of key drugs, Cosentyx and ... circlet of phoenix iro